Valproate: New licensing rules for controversial epilepsy drug

The UK medicines regulator has changed the licence of the drug Valproate to protect women from giving birth to children with malformations or learning defects.Campaigners say it is an "admission" that regulations were "not strong enough in the past".Campaigners have welcomed the move and say that regulators have properly listened to their concerns.